TNF Pharmaceuticals Acquires Exclusive Rights to Light Speed Computing Accelerator.
ByAinvest
Tuesday, Sep 2, 2025 9:35 am ET1min read
TNFA--
LightSolver's Laser Processing Unit (LPU) harnesses light for computation, offering an accelerated method that can solve complex problems at the speed of light. This technology is set to reduce energy costs by up to 90% in cryptocurrency applications, potentially transforming the industry's sustainability [1].
The partnership between TNF and LightSolver is supported by a strategic investment from TNF's largest stockholder, enabling the company to pursue a name change to reflect its new direction. TNF plans to leverage this technology to develop a scalable solution for cryptocurrency infrastructure, aiming to reduce energy consumption and enhance computational efficiency [1].
TNF Pharmaceuticals has also entered into a $7.0 million private placement financing agreement, involving the sale of 7,000 shares of its Series H convertible preferred stock. This funding will support the commercialization and development strategy for the licensed technology [1].
LightSolver, a 2025 World Economic Forum Technology Pioneer, has drawn significant attention for its breakthrough innovation. The company's technology has been recognized by Gartner as a sample vendor in the 2025 Hype Cycle for Data Center Infrastructure Technologies [1].
TNF Pharmaceuticals is positioned to capitalize on the growing momentum behind photonic computing and the future of cryptocurrency infrastructure. The company believes it holds first-mover advantages in this burgeoning industry, setting it up for growth and value creation [1].
References:
[1] https://www.morningstar.com/news/business-wire/20250902945912/tnf-pharmaceuticals-secures-exclusive-global-rights-to-innovative-light-speed-computing-accelerator-for-use-in-cryptocurrency-applications
TNF Pharmaceuticals has acquired exclusive global rights to an innovative light-based computing accelerator for use in cryptocurrency applications. The system, designed by LightSolver, outperforms quantum and supercomputing and solves complex problems unfeasible for GPUs. Supported by a strategic investment from TNF's largest stockholder, the company plans to pursue a name change to reflect its new direction.
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) has secured exclusive global rights to an innovative light-based computing accelerator developed by LightSolver Ltd. This technology, designed to outperform quantum and supercomputing systems, is poised to revolutionize cryptocurrency applications [1].LightSolver's Laser Processing Unit (LPU) harnesses light for computation, offering an accelerated method that can solve complex problems at the speed of light. This technology is set to reduce energy costs by up to 90% in cryptocurrency applications, potentially transforming the industry's sustainability [1].
The partnership between TNF and LightSolver is supported by a strategic investment from TNF's largest stockholder, enabling the company to pursue a name change to reflect its new direction. TNF plans to leverage this technology to develop a scalable solution for cryptocurrency infrastructure, aiming to reduce energy consumption and enhance computational efficiency [1].
TNF Pharmaceuticals has also entered into a $7.0 million private placement financing agreement, involving the sale of 7,000 shares of its Series H convertible preferred stock. This funding will support the commercialization and development strategy for the licensed technology [1].
LightSolver, a 2025 World Economic Forum Technology Pioneer, has drawn significant attention for its breakthrough innovation. The company's technology has been recognized by Gartner as a sample vendor in the 2025 Hype Cycle for Data Center Infrastructure Technologies [1].
TNF Pharmaceuticals is positioned to capitalize on the growing momentum behind photonic computing and the future of cryptocurrency infrastructure. The company believes it holds first-mover advantages in this burgeoning industry, setting it up for growth and value creation [1].
References:
[1] https://www.morningstar.com/news/business-wire/20250902945912/tnf-pharmaceuticals-secures-exclusive-global-rights-to-innovative-light-speed-computing-accelerator-for-use-in-cryptocurrency-applications
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet